acquired
Stage
About
Proof Diagnostics developed CRISPR-based and other genome engineering tools, including a portable diagnostic system for detecting infectious diseases and oncology markers, and proprietary RNA-programmable OMEGA nuclease libraries enabling advanced gene editing.
Explore Proof Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.